Wholesale of pharmaceutical and medical goods
LABMO AS
Revenue 2024
NOK 124,000
Operating profit
NOK −454,000
Equity
NOK 10.8m
Incorporated
2005
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 124k | |
| Total operating costs | 578k | |
| Operating profit (EBIT) | −454k | |
| Net financial items | 355k | |
| Profit for the year | −77k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 10.9m | |
| of which current assets | 97k | |
| Equity | 10.8m | |
| Total liabilities | 155k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.